PATIENT CHARACTERISTICS IMPACTING QUALITY OF LIFE (EQ-5D) OF FEMALES WITH STRESS URINARY INCONTINENCE SYMPTOMS
Author(s)
Douglas Tincello, BSc, MD, Senior Lecturer in Urogynaecology1, Mark Sculpher, PhD, Professor of Health Economics2, Ralf Tunn, PD, Dr, med, Leitender Arzt Fachbereich Urogynakologie3, Deborah Quail, BSc, CStat, Senior Project Statistician4, Louise Timlin, BSc, MSc, Health Outcomes Research Scientist4, Martina Manning, MD, Medical Liaison Manager Endo/Urology51University of Leicester, Leicester, United Kingdom; 2 University of York, York, United Kingdom; 3 St Hedwig Hospitals, Berlin, Germany; 4 Eli Lilly and Company Limited, Surrey, United Kingdom; 5 Lilly Deutschland, BadHomburg, Germany
OBJECTIVES: Describe the characteristics of women seeking treatment for symptoms of stress urinary incontinence (SUI) and to investigate their association with generic quality of life (QOL). METHODS: Stress Urinary Incontinence Treatment Study (SUIT) is a 12-month, observational study in four European countries, evaluating cost-effectiveness of duloxetine compared to other forms of non-surgical intervention in the treatment of symptoms of SUI. Baseline data is presented. A total of 431 physicians observed women seeking treatment for their SUI and recorded the care provided and the outcomes of that care at enrolment, and 3, 6 and 12 months later. The impact of SUI on QOL was assessed using the EuroQol (EQ-5D). Multivariate linear regression was performed on the EQ-5D health state index. RESULTS: A total of 3762 women were enrolled into SUIT; the largest patient group from Germany. The majority were post-menopausal, with a mean age of 58.0 years, were not current smokers and tended to be overweight (mean BMI=27.7), with at least one co-morbidity. Health state index (HSI) scores were significantly (p<0.0001 for all factors except previous surgery, where p=0.049) and independently influenced by, in order of the strength of the association, the total number of incontinence episodes, presence of co-morbidity(ies) affecting QoL, socio-economic status, presence of co-morbidity(ies) affecting incontinence, BMI, urinary incontinence (UI) subtype and previous surgery. Each additional incontinence episode was associated with a decrease in HSI score of 0.002 points, each comorbidity affecting QoL was associated with a HSI score reduction of 0.072 points and each comorbidity directly affecting incontinence was associated with a reduction of 0.040 points. Mixed Urinary Incontinence had a greater negative influence on HSI score than pure SUI. CONCLUSION: This analysis describes the characteristics of patients at the enrolment visit, and demonstrates that the number of incontinence episodes has the greatest impact on the EQ-5D Health State Scores.
Conference/Value in Health Info
2007-10, ISPOR Europe 2007, Dublin, Ireland
Value in Health, Vol. 10, No. 6 (November/December 2007)
Code
PR6
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Urinary/Kidney Disorders
Explore Related HEOR by Topic